Landscapes / Companies
TuHURA Biosciences, Inc. not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
2
in active trials · 1 checked
Trials
3 active
5 since 2021
Drugs2
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 2/3 | 31 Mar 2027Phase 2/3 trial completes | |||
| Next date | 31 Mar 2027 · Phase 2/3 trial completes | ||||
| Also tested for | Advanced Or Metastatic Merkel Cell Carcinoma | ||||
| Open drug page | |||||
TBS-2025not checked |
— |
Phase 1/2 | Dec 2028Phase 1/2 trial completes | ||
| Next date | Dec 2028 · Phase 1/2 trial completes | ||||
| Also tested for | Acute Myeloid Leukemia | ||||
| Open drug page | |||||
About
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021